Hartford Financial Services Group - FXDFR DB REDEEM 15/04/2042 USD 25 EBIT

As of the most recent data (June 2026), HGH shows a EBIT of $2.8B. That compares with $4.2B in the prior-year period — down 31.9% year over year. That is below the Finance sector average of $300B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HGH's EBIT is now $2.8B (was $4.2B) — a 31.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Hartford Financial Services Group - FXDFR DB REDEEM 15/04/2042 USD 25 is outperforming or lagging.

The Finance sector average EBIT is about $300B. Hartford Financial Services Group - FXDFR DB REDEEM 15/04/2042 USD 25 is at $2.8B, which is lower that average. That is roughly 99.1% below the sector mean. Use the comparison chart on this page to see how HGH stacks up against individual peers as well.

Tracking HGH's ebit over time shows whether Hartford Financial Services Group - FXDFR DB REDEEM 15/04/2042 USD 25 is scaling, shrinking, or reshaping that part of the business. The current reading is $2.8B That compares with $4.2B in the prior-year period — down 31.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Hartford Financial Services Group - FXDFR DB REDEEM 15/04/2042 USD 25's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $2.8B) with ownership activity and broader fundamentals.